nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Dynamic CTCF binding directly mediates interactions among cis-regulatory elements essential for hematopoiesis
|
Qi, Qian |
|
|
137 |
10 |
p. 1327-1339 |
artikel |
2 |
Editorial Board
|
|
|
|
137 |
10 |
p. i |
artikel |
3 |
Erythrophagocytosis in a young adult with mycoplasma pneumonia–induced paroxysmal cold hemoglobinuria
|
Eldar, Dor |
|
|
137 |
10 |
p. 1432 |
artikel |
4 |
Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia
|
Duployez, Nicolas |
|
|
137 |
10 |
p. 1424-1428 |
artikel |
5 |
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
|
Agathangelidis, Andreas |
|
|
137 |
10 |
p. 1365-1376 |
artikel |
6 |
How I treat cold agglutinin disease
|
Berentsen, Sigbjørn |
|
|
137 |
10 |
p. 1295-1303 |
artikel |
7 |
How I treat microangiopathic hemolytic anemia in patients with cancer
|
Thomas, M.R. |
|
|
137 |
10 |
p. 1310-1317 |
artikel |
8 |
How I treat paroxysmal nocturnal hemoglobinuria
|
Brodsky, Robert A. |
|
|
137 |
10 |
p. 1304-1309 |
artikel |
9 |
How I treat warm autoimmune hemolytic anemia
|
Barcellini, Wilma |
|
|
137 |
10 |
p. 1283-1294 |
artikel |
10 |
Immune escape mechanisms for TCRLBCL
|
Chan, Wing C. |
|
|
137 |
10 |
p. 1274-1276 |
artikel |
11 |
Introduction to a How I Treat series on acquired hemolytic anemia
|
Cazzola, Mario |
|
|
137 |
10 |
p. 1269 |
artikel |
12 |
Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?
|
Shah, Nirav N. |
|
|
137 |
10 |
p. 1416-1423 |
artikel |
13 |
Mixing “good and bad” annoys neutrophils
|
Trompouki, Eirini |
|
|
137 |
10 |
p. 1272-1274 |
artikel |
14 |
Natural IgM antibodies help fend off thrombosis
|
Haskard, Dorian O. |
|
|
137 |
10 |
p. 1280-1281 |
artikel |
15 |
Natural IgM antibodies inhibit microvesicle-driven coagulation and thrombosis
|
Obermayer, Georg |
|
|
137 |
10 |
p. 1406-1415 |
artikel |
16 |
PD-1 blockade for untreated Hodgkin lymphoma
|
Moskowitz, Alison J. |
|
|
137 |
10 |
p. 1271-1272 |
artikel |
17 |
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma
|
Allen, Pamela B. |
|
|
137 |
10 |
p. 1318-1326 |
artikel |
18 |
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia
|
Xiao, Wenbin |
|
|
137 |
10 |
p. 1377-1391 |
artikel |
19 |
RUNX1 germline variants in RUNX1-mutant AML: how frequent?
|
Ernst, Martijn P.T. |
|
|
137 |
10 |
p. 1428-1431 |
artikel |
20 |
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma
|
Griffin, Gabriel K. |
|
|
137 |
10 |
p. 1353-1364 |
artikel |
21 |
SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing
|
Schürch, Christoph |
|
|
137 |
10 |
p. 1340-1352 |
artikel |
22 |
Targeting the p-D-C: easy as C-D-1-2-3?
|
Pemmaraju, Naveen |
|
|
137 |
10 |
p. 1277-1278 |
artikel |
23 |
Xenotropic and polytropic retrovirus receptor 1 regulates procoagulant platelet polyphosphate
|
Mailer, Reiner K. |
|
|
137 |
10 |
p. 1392-1405 |
artikel |
24 |
XPoRting (poly)phosphates limits thrombosis
|
Stegner, David |
|
|
137 |
10 |
p. 1278-1280 |
artikel |